Biopharma financing for the first half of 2025 totaled $28.7 billion, marking a 59% decline compared with 2024 yet aligning with typical pre-pandemic levels. June 2025 saw a rebound with $7.38 billion raised across 99 transactions. Digital health startups raised $6.4 billion in the first half of 2025, dominated by AI-focused ventures, signaling growing investor confidence and market maturation despite looming policy uncertainties. Med-tech and biopharma companies continue to engage in financings, grants, and partnerships to support ongoing innovation.